ACHV vs. HALO
ACHV (Achieve Life Sciences, Inc.) and HALO (Halozyme Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ACHV returned -45.09%/yr vs 23.38%/yr for HALO. At a 0.18 correlation, their price movements are largely independent.
Performance
ACHV vs. HALO - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with ACHV having a 2.62% return and HALO slightly lower at 2.51%. Over the past 10 years, ACHV has underperformed HALO with an annualized return of -45.09%, while HALO has yielded a comparatively higher 23.38% annualized return.
ACHV
- 1D
- 5.15%
- 1M
- 8.74%
- YTD
- 2.62%
- 6M
- 14.35%
- 1Y
- 52.24%
- 3Y*
- -4.79%
- 5Y*
- -9.48%
- 10Y*
- -45.09%
HALO
- 1D
- 0.64%
- 1M
- 0.98%
- YTD
- 2.51%
- 6M
- 1.22%
- 1Y
- 30.64%
- 3Y*
- 26.43%
- 5Y*
- 9.85%
- 10Y*
- 23.38%
ACHV vs. HALO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ACHV Achieve Life Sciences, Inc. | 2.62% | 41.19% | -14.56% | 68.16% | -68.51% | -3.95% | -23.58% | -56.20% | -90.99% | -75.57% |
HALO Halozyme Therapeutics, Inc. | 2.51% | 40.77% | 29.36% | -35.04% | 41.51% | -5.85% | 140.89% | 21.19% | -27.79% | 105.06% |
Correlation
The correlation between ACHV and HALO is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Mar 16, 2004 | 0.18 |
Fundamentals
ACHV:
$272.25M
HALO:
$8.48B
ACHV:
-$1.08
HALO:
$2.87
ACHV:
25.50
HALO:
38.60
ACHV:
$0.00
HALO:
$1.51B
ACHV:
-$111.00K
HALO:
$1.23B
ACHV:
-$41.34M
HALO:
$980.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACHV vs. HALO — Risk / Return Rank
ACHV
HALO
ACHV vs. HALO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Achieve Life Sciences, Inc. (ACHV) and Halozyme Therapeutics, Inc. (HALO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACHV | HALO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.49 | ||
| Sortino ratioReturn per unit of downside risk | -0.09 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.19 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 0.96 | 1.28 | -0.31 |
| Martin ratioReturn relative to average drawdown | 2.15 | 2.38 | -0.23 |
Loading charts...
Drawdowns
ACHV vs. HALO - Drawdown Comparison
The maximum ACHV drawdown since its inception was -100.00%, which is greater than HALO's maximum drawdown of -74.26%. Use the drawdown chart below to compare losses from any high point for ACHV and HALO.
Loading charts...
Drawdown Indicators
| ACHV | HALO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -74.26% | -25.74% |
Max Drawdown (1Y)Largest decline over 1 year | -54.55% | -24.13% | -30.42% |
Max Drawdown (3Y)Largest decline over 3 years | -66.58% | -33.92% | -32.66% |
Max Drawdown (5Y)Largest decline over 5 years | -80.11% | -49.06% | -31.05% |
Max Drawdown (10Y)Largest decline over 10 years | -99.91% | -49.06% | -50.85% |
Current DrawdownCurrent decline from peak | -99.99% | -15.07% | -84.92% |
Average DrawdownAverage peak-to-trough decline | -83.85% | -31.86% | -51.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.34% | 12.88% | +11.46% |
Volatility
ACHV vs. HALO - Volatility Comparison
Achieve Life Sciences, Inc. (ACHV) has a higher volatility of 21.60% compared to Halozyme Therapeutics, Inc. (HALO) at 8.94%. This indicates that ACHV's price experiences larger fluctuations and is considered to be riskier than HALO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACHV | HALO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.60% | 8.94% | +12.66% |
Volatility (6M)Calculated over the trailing 6-month period | 68.04% | 24.09% | +43.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 100.86% | 30.40% | +70.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.40% | 39.43% | +34.97% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.51% | 42.82% | +48.69% |
Dividends
ACHV vs. HALO - Dividend Comparison
Neither ACHV nor HALO has paid dividends to shareholders.
Financials
ACHV vs. HALO - Financials Comparison
This section allows you to compare key financial metrics between Achieve Life Sciences, Inc. and Halozyme Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ACHV and HALO have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACHV has higher volatility (21.60%) compared to HALO (8.94%). In terms of maximum drawdown, ACHV dropped -100.00% vs HALO's -74.26%.
HALO currently has the higher Sharpe Ratio (1.01 vs 0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACHV and HALO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer